Reaction
Granulomatosis With Polyangiitis reporting signals
As of the last recalculation, Granulomatosis With Polyangiitis appears in 1,175 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED (PRR 85.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Diphenhydramine Hydrochloride Capsule, Liquid Filled | 95 | 85.6 | 86.0 |
| Rituximab | 426 | 55.4 | 55.5 |
| Ciclesonide | 29 | 38.6 | 38.7 |
| Risedronate Sodium | 62 | 37.2 | 37.3 |
| Methylprednisolone | 223 | 35.0 | 35.1 |
| Azathioprine | 140 | 31.8 | 31.9 |
| Diphenhydramine Hcl | 18 | 29.1 | 29.1 |
| Diphenhydramine Hydrochloride | 211 | 27.3 | 27.3 |
| Methylprednisolone Sodium Succinate | 67 | 27.1 | 27.1 |
| Diphenhydramine | 62 | 18.3 | 18.3 |
| Atovaquone | 8 | 17.7 | 17.7 |
| Cefuroxime | 11 | 17.2 | 17.2 |
| Sulfamethoxazole And Trimethoprim | 71 | 15.8 | 15.8 |
| Felodipine Extended-Release Tablets | 10 | 15.7 | 15.7 |
| Felodipine | 10 | 15.7 | 15.7 |
| Rabeprazole | 19 | 15.4 | 15.4 |
| Cyclophosphamide Injection, Solution | 112 | 12.3 | 12.3 |
| Cyclophosphamide | 112 | 12.3 | 12.3 |
| Cyclophosphamide For Injection | 112 | 12.3 | 12.3 |
| Amikacin | 11 | 11.5 | 11.5 |
| Mepolizumab | 24 | 8.7 | 8.7 |
| Fluticasone Furoate And Vilanterol Trifenatate | 16 | 8.0 | 8.0 |
| Entecavir | 5 | 7.6 | 7.6 |
| Durvalumab | 7 | 6.1 | 6.1 |
| Isotretinoin | 14 | 5.1 | 5.1 |